Veeva Systems (VEEV) Tops Q2 EPS by 8c; Guides Higher

Veeva Systems (NYSE: VEEV) reported Q2 EPS of $0.72, $0.08 better than the analyst estimate of $0.64. Revenue for the quarter came in at $353.7 million versus the consensus estimate of $340.12 million.

“We are focused on helping the industry as the move to streamline drug development and enable digital engagement has gone from strategic imperative to operational necessity,” said CEO Peter Gassner. “Our team\'s dedication to customer success, bringing creative solutions, and delivering significant product innovations with speed, is more important than ever as life sciences steps up to meet the challenge of a lifetime.”

GUIDANCE:

Veeva Systems sees Q3 2021 EPS of $0.66-$0.68, versus the consensus of $0.63. Veeva Systems sees Q3 2021 revenue of $360-362 million, versus the consensus of $347 million.

Veeva Systems sees FY2021 EPS of $2.64-$2.67, versus the consensus of $2.56. Veeva Systems sees FY2021 revenue of $1.415-1.42 billion, versus the consensus of $1.39 billion.

For earnings history and earnings-related data on Veeva Systems (VEEV) click here.

You May Also Be Interested In

• Schlumberger (SLB) earnings in-line, revenue beats expectations
• Parke Bancorp (PKBK) Reports Q1 EPS of $0.51
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance